Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP602135.RAn8QMhq7GTQZp6OAlpb-f0VUO9F9pe8VbIGdXxCEw4gU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP602135.RAn8QMhq7GTQZp6OAlpb-f0VUO9F9pe8VbIGdXxCEw4gU130_assertion type Assertion NP602135.RAn8QMhq7GTQZp6OAlpb-f0VUO9F9pe8VbIGdXxCEw4gU130_head.
- NP602135.RAn8QMhq7GTQZp6OAlpb-f0VUO9F9pe8VbIGdXxCEw4gU130_assertion description "[Confirmation of these findings is needed before the Kozak sequence variant can be accepted as a potential marker for personalized treatment of affective disorders with drugs targeting the metabotropic glutamate receptor 3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP602135.RAn8QMhq7GTQZp6OAlpb-f0VUO9F9pe8VbIGdXxCEw4gU130_provenance.
- NP602135.RAn8QMhq7GTQZp6OAlpb-f0VUO9F9pe8VbIGdXxCEw4gU130_assertion evidence source_evidence_literature NP602135.RAn8QMhq7GTQZp6OAlpb-f0VUO9F9pe8VbIGdXxCEw4gU130_provenance.
- NP602135.RAn8QMhq7GTQZp6OAlpb-f0VUO9F9pe8VbIGdXxCEw4gU130_assertion SIO_000772 23575746 NP602135.RAn8QMhq7GTQZp6OAlpb-f0VUO9F9pe8VbIGdXxCEw4gU130_provenance.
- NP602135.RAn8QMhq7GTQZp6OAlpb-f0VUO9F9pe8VbIGdXxCEw4gU130_assertion wasDerivedFrom befree-20140225 NP602135.RAn8QMhq7GTQZp6OAlpb-f0VUO9F9pe8VbIGdXxCEw4gU130_provenance.
- NP602135.RAn8QMhq7GTQZp6OAlpb-f0VUO9F9pe8VbIGdXxCEw4gU130_assertion wasGeneratedBy ECO_0000203 NP602135.RAn8QMhq7GTQZp6OAlpb-f0VUO9F9pe8VbIGdXxCEw4gU130_provenance.